[Reposted from the National Bleeding Disorders Foundation]

January 26, 2024

Takeda announced today that it is conducting a voluntary market withdrawal for two product lots of 650 IU VONVENDI® [von Willebrand factor] in the U.S. Takeda said that the withdrawal is being conducted out of an abundance of caution due to misprinted product labels with the incorrect expiration date.

The expiration date printed on the label on the outside of the package of the affected lots is six months after the actual expiration date (January 27, 2025).

Please note that HFA and NBDF do not recommend, endorse, or make any representation about the efficacy, appropriateness, or suitability of any specific products, treatments, or opinions. If you have any questions or concerns about your medical treatment, please consult your physician.

Click Here to Read the VONVENDI® Market Withdrawal Patient Letter